Stock Rich List
#1715 on the rich list of 14,452 insiders

Emil D. Kakkis

President & CEO at Ultragenyx Pharmaceutical. Based in Novato, California.

$83.6M
in disclosed stock, −$2.5M (−2.88%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1715th of 14,452
Companies held
1
Largest holding
RARE, 100.0% of total
Latest SEC filing
Apr 16, 2026

What the $83.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Ultragenyx Pharmaceutical RARE
Common Stock
Through Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 20092,158,985$17.22$37.2M44.5%Form 4, Mar 1, 2026
Ultragenyx Pharmaceutical RARE
Common Stock
Through Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009091,758,985$17.22$30.3M36.2%Form 4, Apr 16, 2026
Ultragenyx Pharmaceutical RARE
Common Stock
Directly735,739$17.22$12.7M15.2%Form 4, Apr 16, 2026
Ultragenyx Pharmaceutical RARE
Common Stock
Through GRAT200,000$17.22$3.4M4.1%Form 4, Apr 16, 2026

Share counts are the amounts Emil D. Kakkis reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Mar 2, 2026SoldRARE54,404$22.80$1.2MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1712Kenneth S. Wilson
Chief Executive Officer, Jabil. St. Petersburg, FL
$83.7M−$326K (−0.39%)
1713Michael J Dominguez
10% owner, DoubleVerify Holdings. Providence, RI
$83.7M−$75K (−0.09%)
1714Mark P. Stevenson
Retiring Executive VP & COO, Thermo Fisher Scientific. Davidson, NC
$83.6M−$503K (−0.60%)
1715Emil D. Kakkis
President & CEO, Ultragenyx Pharmaceutical. Novato, CA
$83.6M−$2.5M (−2.88%)
1716Alma Gregory Sorensen
Chief Strategy Officer, RadNet. Los Angeles, CA
$83.5M−$2.8M (−3.22%)
1717Warren Gouk
Chief Administrative Officer, LifeStance Health Group. Scottsdale, AZ
$83.5M−$2.7M (−3.12%)
1718Jacqueline F. Parker
10% owner, Covenant Logistics Group. Chattanooga, TN
$83.5M−$2.2M (−2.51%)

Other Ultragenyx Pharmaceutical insiders

All RARE insiders

Questions

How much stock does Emil D. Kakkis own?

Emil D. Kakkis holds $83,580,869 in listed stock based on SEC filings and current prices, mostly Ultragenyx Pharmaceutical (RARE). That ranks 1715th on the Stock Rich List.

Is this Emil D. Kakkis's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Emil D. Kakkis last buy or sell stock?

The most recent open-market trade on file is a sale of 54,404 RARE shares on Mar 2, 2026 at $22.80.